Results 201 to 210 of about 419,079 (384)

Vaccination in Multiple Myeloma: Challenges and Strategies. [PDF]

Eur J Haematol
ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy characterized by profound immunosuppression resulting from both disease‐related mechanisms and treatment‐induced immune dysfunction. This compromised immune status markedly increases susceptibility to infections, a leading cause of morbidity and mortality in MM patients.
Martino EA, Vigna E, Bruzzese A, Amodio N, Lucia E, Olivito V, Labanca C, Caserta S, Mendicino F, Morabito F, Gentile M.   +10 more
europepmc   +2 more sources

The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa [PDF]

, 2000
W. John Edmunds
openalex   +1 more source

Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults

Human Vaccines, 2011
F. Hernández-Bernal, Arístides Aguilar-Betancourt, Virginia Aljovin, G. Arias, C. Valenzuela, Karen Pérez de Alejo, Karina Hernández, Orcilia Oquendo, Niurka Figueredo, Nelvis Figueroa, A. Musacchio, G. Véliz, Elizeth García, Alina D Mollineda, Ana Isabel Juvier, Janette Trujillo, A. Delahanty, Darién Ortega, Z. Cinza, V. L. M. González   +19 more
semanticscholar   +1 more source

Posttranslational modifications of heterologous proteins expressed in Nicotiana benthamiana

Plant Biotechnology Journal, EarlyView.
Summary The success of Nicotiana benthamiana as a workhorse for heterologous protein production is closely linked to its accessibility and tolerance to genetic manipulation, allowing efficient engineering of posttranslational protein modifications (PTMs) that are critical for the function and stability of heterologous proteins.
Kathrin Göritzer, Somanath Kallolimath, Richard Strasser   +2 more
wiley   +1 more source

Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccines. [PDF]

Hum Vaccin Immunother
Bruxvoort KJ, Sy LS, Slezak J, Ackerson BK, Qian L, Qiu S, Solano Z, Reynolds K.   +7 more
europepmc   +1 more source

cDNA clone of non-A non-B hepatitis virus (NANB) post transfusion and its use — DNA sequence; potential application as recombinant vaccine; DNA probe application in disease diagnosis

, 1991

openalex   +1 more source

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C [PDF]

, 2000
Marcus Wiedmann, Uwe G. Liebert, U. Oesen, H. Porst, Manfred Wiese, Sabine Schroeder, Ulrich Halm, Joachim Mössner, Frieder Berr   +8 more
openalex   +1 more source

Protein engineering strategies to optimise recombinant product synthesis and accumulation in Nicotiana benthamiana

Plant Biotechnology Journal, EarlyView.
Summary In plant molecular farming, recombinant products include traditional protein targets, such as antibodies, antigens, and enzymes, but also increasingly refers to high‐value peptides, and small molecules produced by heterologous enzymatic pathways.
Maxim D. Harding, Frank Sainsbury
wiley   +1 more source

Safety of Hepatitis B Vaccines (Monovalent or as Part of Combination) in Preterm Infants: A Systematic Review. [PDF]

Vaccines (Basel)
Tee QW, Odisho R, Purcell E, Purcell R, Buttery J, Nold-Petry CA, Nold MF, Nold MF, Malhotra A.   +8 more
europepmc   +1 more source

Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer [PDF]

, 2000
S. Zucchelli, Stefania Capone, Elena Fattori, Antonella Folgori, Annalise Di Marco, Danilo R. Casimiro, Adam Simon, Ralph Laufer, Nicola La Monica, Riccardo Cortese, Alfredo Nicosia   +10 more
openalex   +1 more source